Search Result "PD-L1."


Mini-Review Article

PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives

Journal: Current Drug Targets
Volume: 22 Issue: 2 Year: 2021 Page: 162-170
Author(s): Thomas Gevaert,Alessia Cimadamore,Rodolfo Montironi,Markus Eckstein

Systematic Review Article

Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis

Journal: Current Cancer Drug Targets
Volume: 21 Issue: 0 Year: 2021 Page: 1-10
Author(s): Minyong Peng,Shan Li,Hui Xiang,Wen Huang,Weiling Mao,Di Xu

Review Article

The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy

Journal: Current Medicinal Chemistry
Volume: 28 Issue: 5 Year: 2021 Page: 893-909
Author(s): Lifang Zhang,Yu Zhao,Quanmei Tu,Xiangyang Xue,Xueqiong Zhu,Kong-Nan Zhao

Research Article

Elucidation of S-Allylcysteine Role in Inducing Apoptosis by Inhibiting PD-L1 Expression in Human Lung Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2021 Page: 484-493
Author(s): Fahad Khan,Pratibha Pandey,Rashmi Mishra,Mohd. Arif,Ambuj Kumar,Asif Jafri,Rupa Mazumder

Research Article

DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC

Journal: Current Cancer Drug Targets
Volume: 21 Issue: 0 Year: 2021 Page: 1-11
Author(s): Jinhuan Wei,Jun Lu,Yun Cao,Gaosheng Yao,Yong Huang,Hongwei Zhao,Yihui Pan,Zihao Feng,Zhenhua Chen,Wei Chen,Junhang Luo,Jiazheng Cao

Research Article

Relationship with Programmed Cell Death Ligand 1 (Pd-L1) and Dti Features in Brain Metastases of Non-Small Cell Lung Cancer: A Preliminary Study

Journal: Current Medical Imaging
Volume: 17 Issue: 0 Year: 2021 Page: 1-5
Author(s): Temel Fatih Yilmaz,İsmail Yurtsever,Hacı Mehmet Turk,Mehmet Ali Gultekin,Mehmet Besiroglu,Dilek Hacer Cesme,Abdallah T M Shbair,Alpay Alkan

Review Article

Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 17 Issue: 2 Year: 2021 Page: 148-158
Author(s): Shvetank Bhatt,Jovita Kanoujia,Arghya K. Dhar,Rakesh K. Singh,Jayaraman Rajangam

Review Article

The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3(Tim-3) in Designing Novel Immunotherapy for Bladder Cancer

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 1 Year: 2021 Page: 2131-2146
Author(s): Monireh Mohsenzadegan,Parizad Bavandpour,Mohammad Reza Nowroozi,Erfan Amini,Masoumeh Kourosh-Arami,Seyed Ali Momeni,Saied Bokaie,Laleh Sharifi

General Review Article

Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 16 Issue: 2 Year: 2021 Page: 239-248
Author(s): Jing Bai,Ping Liang,Qian Li,Rui Feng,Jiang Liu

Mini-Review Article

Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors

Journal: Current Drug Targets
Volume: 22 Issue: 9 Year: 2021 Page: 968-976
Author(s): Csongor György Lengyel

Previous   Next

Go To   Results 1 - 1 of 102

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy